These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6221511)

  • 21. Pharmacological manipulation of canine cyclooxygenase and thromboxane synthetase in vivo: differential renal and platelet recovery rates.
    Oshima T; McCluskey ER; Honda A; Needleman P
    J Pharmacol Exp Ther; 1984 May; 229(2):598-602. PubMed ID: 6425495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosynthesis of thromboxanes.
    Hammarström S; Diczfalusy U
    Adv Prostaglandin Thromboxane Res; 1980; 6():267-74. PubMed ID: 6770598
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe bleeding associated with defective thromboxane synthetase.
    Mestel F; Oetliker O; Beck E; Felix R; Imbach P; Wagner HP
    Lancet; 1980 Jan; 1(8160):157. PubMed ID: 6101498
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of thromboxane synthetase inhibitors on the action of bronchoactive agents and on arachidonate metabolism in the guinea pig tracheobronchopulmonary system].
    Kitamura S; Ishihara Y; Takaku F
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jan; 22(1):3-8. PubMed ID: 6539836
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
    Tai HH; Lee N; Tai CL
    Adv Prostaglandin Thromboxane Res; 1980; 6():447-52. PubMed ID: 7189951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 27. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of cytochrome P450 from filamentous fungus Rhyzopus nigricans.
    Makovec T; Breskvar K
    Pflugers Arch; 2000; 439(3 Suppl):R111-2. PubMed ID: 10653160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel pyridobenzazepinone derivative with long lasting thromboxane synthase inhibition.
    Miki I; Kishibayashi N; Takeda M; Suzuki K; Obase H; Ishii A
    Arzneimittelforschung; 1995 Oct; 45(10):1066-70. PubMed ID: 8595060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane synthetase.
    Sun FF
    Biochem Biophys Res Commun; 1977 Feb; 74(4):1432-40. PubMed ID: 843369
    [No Abstract]   [Full Text] [Related]  

  • 31. Whole-blood assays for evaluation of thromboxane synthase inhibition.
    Spokas EG; Nicholson NS; Suleymanov OD; Walsh GM; Tuffin D
    Methods Mol Biol; 1999; 120():249-56. PubMed ID: 10343321
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical prospects for a thromboxane synthetase inhibitor. A Pfizer Central Research Symposium--26th-27th March, 1982.
    Br J Clin Pharmacol; 1983; 15 Suppl 1():5S-139S. PubMed ID: 6681704
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
    Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
    [No Abstract]   [Full Text] [Related]  

  • 34. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isomers of trans fatty acids modify the activity of platelet 12-P lipoxygenase and cyclooxygenase/thromboxane synthase.
    Stachowska E; Dołegowska B; Olszewska M; Gutowska I; Chlubek D
    Nutrition; 2004 Jun; 20(6):570-1. PubMed ID: 15165621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of a thromboxane synthetase inhibitor for the protection of platelet number and function during extracorporeal circulation. Experimental study].
    Massonnet Castel S; Pelissier E; Fabiani JN; Terrier E
    Agressologie; 1983 Dec; 24(12):605-8. PubMed ID: 6686919
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 38. Thromboxane mediates pulmonary vasoconstriction and contributes to cytotoxicity in pig lungs perfused with fresh human blood.
    Pierson RN; Parker RE
    Transplant Proc; 1996 Apr; 28(2):625. PubMed ID: 8623309
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Platelet thromboxane synthase deficiency].
    Fuse I
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):374-6. PubMed ID: 9833518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.